Evaluation of carboplatin pharmacokinetics in the absence and presence of paclitaxel.

作者
Coleman K. Obasaju,Steven W. Johnson,André Rogatko,Deborah L. Kilpatrick,James M. Brennan,Thomas C. Hamilton,Robert F. Ozols,Peter James O'Dwyer,James M. Gallo
出处
期刊:PubMed [National Institutes of Health]
卷期号:2 (3): 549-52 被引量:45
链接
标识
摘要

In a clinical trial of paclitaxel (Taxol) and carboplatin in combination, the severity of thrombocytopenia was less than would be expected with an equivalent dose of carboplatin alone. To determine whether a pharmacokinetic interaction was responsible for this observation, the effect of pretreatment with Taxol on the pharmacokinetics of carboplatin was examined in 11 patients. Each patient was randomized to one of two treatment groups that determined the order of drug treatments. The treatments were carboplatin as a 30-min infusion alone or immediately following 175 mg/m2 Taxol administered as a 3-h i.v. infusion. The treatments were separated by 1 week. The carboplatin dose was chosen to produce a target area under the concentration-time curve (AUC) of 3.75 mg-min/ml according to a previously published formula (A. H. Calvert et al., J. Clin Oncol., 7: 1748-1756, 1989). The mean administered dose of carboplatin was 338 mg. Serial blood samples were collected over 24 h and analyzed for total and free platinum, and, in some patients, Taxol. The pharmacokinetics of carboplatin (i.e., total clearance and volume of distribution at steady state), was not significantly affected by pretreatment with Taxol. Total clearances of carboplatin were 67.2 +/- 28.8 ml/min and 64.6 +/- 27.9 ml/min in the absence and presence of Taxol, respectively (P = 0.56). The AUC of free carboplatin (3.45 mg-min/ml) obtained in the absence of Taxol was not significantly different from that measured in the presence of Taxol (3.27 mg-min/ml). The AUC of carboplatin in both the absence and presence of Taxol agreed with the projected target AUC of 3.75 mg-min/ml. In conclusion, the application of an individualized dosing strategy is valid for the calculation of the carboplatin dose in this combination. The pharmacokinetics of carboplatin is not altered by pretreatment with Taxol at a standard dose, and a pharmacokinetic interaction is not responsible for the altered toxicity of the combination.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
上官若男的应助被wlin采纳,获得10
刚刚
科研通AI6.2的应助被辛勤电源采纳,获得30
刚刚
刚刚
wangdan发布了新的文献求助10
刚刚
华仔的应助被bobopoi采纳,获得10
1秒前
1秒前
luoman5656完成签到,获得积分10
1秒前
楠湘发布了新的文献求助10
1秒前
2秒前
彩虹完成签到 ,获得积分10
2秒前
ynuxb完成签到,获得积分10
3秒前
3秒前
无极微光的应助被可耐的飞槐采纳,获得20
3秒前
3秒前
4秒前
4秒前
4秒前
JamesPei的应助被zhikaiyici采纳,获得30
4秒前
nini发布了新的文献求助20
5秒前
5秒前
Molly0303发布了新的文献求助10
5秒前
6秒前
天天快乐的应助被果奶酱采纳,获得10
6秒前
英姑的应助被Deb采纳,获得10
6秒前
6秒前
6秒前
嘻嘻哈哈发布了新的文献求助210
7秒前
zyy发布了新的文献求助10
7秒前
zzk发布了新的文献求助10
7秒前
负责的绿柏完成签到,获得积分10
7秒前
打打的应助被薯条采纳,获得10
7秒前
王子ST完成签到,获得积分10
7秒前
王珑完成签到 ,获得积分10
7秒前
8秒前
8秒前
tang发布了新的文献求助10
8秒前
欧耶完成签到 ,获得积分10
8秒前
zjz1的应助被yi采纳,获得10
8秒前
8秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183204
求助须知:如何正确求助?哪些是违规求助? 9572434
关于积分的说明 21825655
捐赠科研通 7779988
什么是DOI,文献DOI怎么找? 3433852
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480148